VWF and hematocrit: ELISA test results showed that s‐HT patients had a significantly lower vWF levels than the non‐s‐HT group (26.57 [13.64–37.18] vs. 42.00 [26.02–55.52] ng/mL, p < 0.001) in the prospective study cohort.